Browse Category

NYSE:OSCR News 24 November 2025 - 9 January 2026

Oscar Health stock steadies premarket after ACA subsidies vote; UBS lifts rating

Oscar Health stock steadies premarket after ACA subsidies vote; UBS lifts rating

New York, Jan 9, 2026, 05:47 EST — Premarket Oscar Health shares were flat at $16.90 in premarket trading on Friday, after rising 2.6% in the prior session, as investors weighed a U.S. House vote to restore expired Affordable Care Act subsidies and fresh analyst commentary. (Investing.com) The subsidies, a form of tax credit that lowers monthly premiums for many people who buy coverage through the ACA marketplaces, are a live wire for insurers like Oscar that sell heavily on the exchanges. They lapsed at the end of 2025, and the sticker shock is already showing up in what consumers
Oscar Health Stock (OSCR) News Today: ACA Subsidy Cliff, Analyst Price Targets, and 2026 Open Enrollment Signals (Dec. 15, 2025)

Oscar Health Stock (OSCR) News Today: ACA Subsidy Cliff, Analyst Price Targets, and 2026 Open Enrollment Signals (Dec. 15, 2025)

Oscar Health, Inc. (NYSE: OSCR) is back in the spotlight on December 15, 2025, as investors track a rare triple intersection of (1) U.S. health-policy headlines, (2) new analyst coverage and price-target resets, and (3) the most time-sensitive part of Affordable Care Act (ACA) open enrollment. As of the latest available market data, OSCR last traded around $16.63, with a market cap near $4.24 billion and a 52-week range of roughly $11.20 to $22.40. This is not a “set it and forget it” stock. Oscar is tightly linked to the economics of ACA marketplaces—and this week, the ACA story is
Oscar Health (OSCR) Stock Today: Fresh Analyst Coverage, Big 2027 Profit Hopes and Policy Risk in Focus

Oscar Health (OSCR) Stock Today: Fresh Analyst Coverage, Big 2027 Profit Hopes and Policy Risk in Focus

Oscar Health, Inc. (NYSE: OSCR) is back under the market’s spotlight on December 11, 2025, as Wall Street adds new coverage, doubles down on long‑term profit targets, and investors digest another bout of volatility in this high‑growth, high‑risk health‑insurtech name. While legacy giants such as American International Group, Inc. (AIG) dominate traditional insurance lines, Oscar is trying to reinvent health coverage for the Affordable Care Act (ACA) era with a tech‑first platform, AI tools, and aggressive geographic expansion. That experiment is playing out in real time in the stock price. Oscar Health stock today: volatile in the mid‑$15s As of
Oscar Health (OSCR) Stock: Can a 35% Rally Survive Fresh Downgrades and ACA Uncertainty? – December 7, 2025

Oscar Health (OSCR) Stock: Can a 35% Rally Survive Fresh Downgrades and ACA Uncertainty? – December 7, 2025

Oscar Health Inc. (NYSE: OSCR) has just delivered one of the wildest weeks in its short public-market life: the stock jumped roughly 35% on hopes that the White House will extend Affordable Care Act (ACA) subsidies, then ran straight into a wall of new downgrades and rising bearish options activity. Investopedia+2Reuters+2 As of the latest close, Oscar shares trade around $16.77, giving the health-tech insurer a market value of roughly $4.4–4.5 billion. That leaves the stock about 30% below its 52‑week high of $23.80 and roughly 50% above its 52‑week low of $11.20. StockAnalysis+1 Below is a deep dive into
Oscar Health (OSCR) Stock Soars on Obamacare Subsidy Hopes as AI-Powered Virtual Care Rewrites Its Growth Story

Oscar Health (OSCR) Stock Soars on Obamacare Subsidy Hopes as AI-Powered Virtual Care Rewrites Its Growth Story

Oscar Health Inc. (NYSE: OSCR) is back in the spotlight on Monday, November 24, 2025, as its stock surges on reports of a potential extension of Obamacare subsidies — just days after fresh analysis highlighted how AI-driven virtual care, new regional expansions, and a changing Wall Street stance are reshaping the company’s long-term story. Investing.com+2Simply Wall St+2 ACA Subsidy Extension Talk Sends Oscar Health Shares Higher Oscar Health shares jumped sharply in premarket trading on Monday after a report that the White House is preparing to propose a two-year extension of Affordable Care Act (ACA) subsidies, with new limits on

Stock Market Today

Wesfarmers share price: what to watch on ASX next week as results loom

Wesfarmers share price: what to watch on ASX next week as results loom

7 February 2026
Wesfarmers shares closed down 1.33% at A$85.04 on Friday, following a sharp drop in the S&P/ASX 200, which fell 2% for its steepest one-day loss in 10 months. Investors are watching for Australia’s household spending data next week and Wesfarmers’ half-year results due Feb. 19.
Go toTop